Newomics Inc. is a commercial-stage biotechnology company that sells and develops innovative (New) and integrative (Omics) platforms and solutions for precision medicine.

Our award-winning multinozzle emitter splits the incoming flow evenly into multiple smaller streams, thereby dramatically enhancing the ionization efficiency to achieve unprecedented sensitivity, throughput, and robustness for LC-MS.

Any LC-MS application can benefit from the M3 emitter, from clinical diagnostics to biomarker discovery to drug development to food and environmental monitoring to forensic analysis and more. Detailed application notes are available for bottom-up proteomics and targeted proteomics.